Naturally Derived
Protocol develops next‑generation consumer products at the intersection of nature and biotech.
We start with organic and ancestral compounds, apply cutting‑edge science, and create solutions that meet real needs like better sleep and wellness.
Each product is clinically validated, ethically developed, and designed to improve lives while advancing a healthier, more sustainable world.
Protocol bridges natural intelligence with modern science to create trusted, evidence-based health innovations, from consumer health to humanitarian field programs, on one micelle‑engineering platform.
Highly absorbable micelle‑based supplements that outperform conventional products. Formulations that begin with nature and are refined through science.
Biotechnology applied to health outcomes in vulnerable communities: field programs, NGO collaboration, and global health partnerships.
Micelle engineering, compound synergy, and stability optimization, advancing how natural compounds are structured, absorbed, and used by the body.
Delivery systems are often described as if they were interchangeable, and they are not. A micelle, a liposome and a vesicle are built differently and sit at very different sizes, and that determines what each one can carry and how the body handles it. Protocol builds micelles: the smallest of the three, with a single shell around an oil-soluble core. Here is how they compare.
Single shell. An oil-soluble core inside one water-soluble sheath. Diameter varies with how much active is loaded. Protocol builds these from gum arabic, a plant-derived raw material.
Double membrane, hollow. A bubble enclosed by two layers of phospholipid, with a watery interior rather than an oil core, a different architecture for a different payload.
Cellular machinery. A double-membrane compartment cells use to move cargo in and out and to hold reactions apart. It is biology's own transport system, not a formulation format.
Dr. Jerry Thornthwaite begins a career in biophysical chemistry and immunology. Cancer research, cell analysis, and the question that would define Protocol's science: why the body absorbs so little of what nature offers it.
Protocol's micellisation process is engineered in St. Gallen, Switzerland, under pharmaceutical-grade process control.
Malaria remains one of the world's heaviest and most preventable disease burdens, and it falls hardest on the places least able to store, ship, and administer conventional medicine. Protocol plans to begin its humanitarian work in the central and eastern region of the continent, then expand outward from there, with formulations engineered for the realities of field distribution.
Malaria is treatable. It continues at this scale because treatment has to survive the journey to the person who needs it. Much of the burden falls in rural areas that are hours from a clinic, where refrigeration is unreliable and supply chains are long, and where a course of treatment is often started but not finished.
Protocol is building for those conditions rather than around them. A formulation that holds for three years without a cold chain, dosed as oral drops for infants through adults, at a lower dose for the same effect. The aim is a treatment that reaches the last mile intact and is simple enough to be taken to completion.
“Malaria continues because treatment ends too quickly. When you give the body time, steady pressure, the right compounds, and proper immune support, it can do what medicine alone cannot: develop lasting protection.”
Protocol's clinical direction is held by four people: a biophysical chemist who has spent a career on the delivery of natural actives, a biomedical engineer leading research, and two physicians who carry formulation work into practice, patient safety, and standards of care.
A biophysical chemist whose research career spans immunology, cancer prevention, and the micellar delivery of natural actives. His published work on encapsulating compounds such as artemisinin, curcumin, and vitamin C into fatty‑acid micelles underpins Protocol's formulation science.
A fast‑growing team of seasoned experts and emerging talent, united by a single goal: advancing human health through work that raises the standard every time. Select a name to read the full biography.
Protocol works with research institutions, clinical partners, and manufacturers advancing natural compound delivery.